SpineX Inc.
PrivateLast Round
Grant
Sep 26, 2023
Total Funding Raised
$10.47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SpineX Inc. operates in Healthcare & Life Sciences and is based in Fremont, California. Its latest recorded funding round was a Grant round in September 2023.
SpineX Inc. is a clinical-stage medical technology company that develops non-invasive spinal cord neuromodulation devices to treat neurological conditions such as neurogenic bladder and cerebral palsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpineX Inc. Comparables
Compare SpineX Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PathMaker Neurosystems | 88% | |
| ANEUVO | 88% | |
| ONWARD Medical N.V. | 80% |
For institutional investors. Book with your work email.
SpineX Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 26, 2023 | ||||
| Accelerator | Aug 18, 2023 | ||||
| Seed | Aug 4, 2023 | ||||
| Convertible Debt | Mar 31, 2023 | ||||
| Grant | Feb 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SpineX Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cerebral Palsy Alliance | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| The Consortium for Technology & Innovation in Pediatrics | Seed |
| Remarkable | Accelerator |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 83% QoQ, from 6 to 11 employees.
- Jul 20, 2026
Grew 60% QoQ from 5 to 8 employees.
For institutional investors. Book with your work email.
SpineX Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SpineX Inc.'s valuation, stock price, and market status.
Is SpineX Inc. a public or private company?
SpineX Inc. is a private company.
What is the current stock price of SpineX Inc.?
SpineX Inc. is a private company, so its shares have no public market price. Caplight tracks SpineX Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SpineX Inc. worth (valuation)?
Valuation information for SpineX Inc. is not publicly available.
Can I buy SpineX Inc. stock?
SpineX Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SpineX Inc.'s last funding round?
SpineX Inc.'s most recent funding round was Grant on September 26, 2023.
Who are the main investors in SpineX Inc.?
Key investors in SpineX Inc. include Cerebral Palsy Alliance, National Institute of Diabetes and Digestive and Kidney Diseases, The Consortium for Technology & Innovation in Pediatrics, Remarkable, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Will SpineX Inc. IPO soon?
No public IPO plans have been announced for SpineX Inc..
How can I track SpineX Inc. secondary market activity?
Caplight tracks bids, offers, and trades in SpineX Inc.'s shares on secondary markets.